News | September 15, 2022
AstraZeneca launches up-skilling program iPHARMACY
The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala
The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala
Rymti is indicated in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, plaque psoriasis, and paediatric plaque psoriasis
The reliability of their products, evidenced by their inclusion in the WHO emergency use list, has further improved with the addition of Takara Bio's enzymes.
The Prime Minister addressed a major problem that is affecting the income of farmers which is the diseases of animals and emphasised that in this direction India is working towards universal vaccination of animals
This association between the two esteemed organizations allows Medvarsity to significantly – and positively – impact healthcare education
If implemented across the world, it has the capability to save over 100,000 lives annually
Japan’s Ministry of Health, Labour and Welfare (MHLW) has recently approved AstraZeneca's long-acting antibody combination “Evusheld” for the prevention ) and treatment of COVID-19.
In first-line metastatic NSCLC, KEYTRUDA-based regimens have now shown a five-year survival benefit in four trials
The Phase 3 SOLO-1 trial demonstrated 67% of advanced ovarian cancer patients with BRCA mutations receiving LYNPARZA were alive at seven years versus 47% of placebo patients
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
Subscribe To Our Newsletter & Stay Updated
